PAUL Mannion, Blackmores Director of Product Innovation, has been elected as President of the Board of Complementary Medicines Australia (CMA).
Mannion joined the CMA Board in 2012, and takes over the President role from Dusko Pejnovic, CEO of Lipa Pharmaceuticals who becomes CMA Vice President.
CMA CEO Carl Gibson said the organisation was excited about taking the industry forward, amid "growing acceptance of the benefits of quality therapeutic complementary medicines as an element of preventive health".
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Oct 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Oct 18
